Surg Today (2018) 48:87–94 https://doi.org/10.1007/s00595-017-1558-y ORIGINAL ARTICLE Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single‑center retrospective analysis with long follow‑up 1 1 1 1 Yoshinari Ogawa · Katsumi Ikeda · Chika Watanabe · Yuri Kamei · 2 2 3 3 Shinya Tokunaga · Yuko Tsuboguchi · Takeshi Inoue · Hiroko Fukushima · Makoto Ichiki Received: 25 March 2017 / Accepted: 28 May 2017 / Published online: 24 June 2017 © Springer Japan KK 2017 Abstract follow-up time of 63 months. Of the 33 patients who did Purpose Sentinel node biopsy (SNB) after neoadjuvant not undergo ALND, 10 suffered recurrence (33%). One therapy (NAT) for breast cancer remains controversial. patient (3%) had recurrence in an axillary lymph node and We conducted a retrospective study of patients who under- four had recurrence in a supraclavicular lymph node. went SNB after NAT to evaluate the effectiveness of this Conclusion Axillary SNB after NAT did not affect the axil- procedure. lary failure rate or the prognosis. SNB may be a reliable Methods A consecutive 105 women with locally advanced procedure, even after NAT. breast cancer (cT1–4, cN0–3, M0) were treated with NAT between 2006 and 2015. The
Surgery Today – Springer Journals
Published: Jun 24, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud